Cases 1 - 10 of 90
Federal Trade Commission V. Amgen Inc., et al.
as 1:2023cv03053
Counter Defendant:
Federal Trade Commission
Defendant:
Amgen Inc. and Horizon Therapeutics PLC
Plaintiff:
New York, State of, State of California, State of Illinois and others
Intervenor:
Regeneron Pharmaceuticals, Inc.
Cause Of Action: 15 U.S.C. § 0053 Federal Trade Commission Act
Third Party Subpoenas Ad Testificandum, et al v. Nexus Pharmaceuticals, Inc
as 1:2023cv02871
In Re:
THIRD PARTY SUBPOENAS AD TESTIFICANDUM
Petitioner:
Ingenus Pharmaceuticals, LLC and Leiutis Pharmaceuticals LLP
Respondent:
Nexus pharmaceuticals, Inc.
Cause Of Action: 02 U.S.C. § 431 Fed. Election Commission: Failure Enforce Compliance
In Re: Opana ER Antitrust Litigation
as 1:2014cv10150
In Re:
Opana ER Antitrust Litigation
Plaintiff:
Rochester Drug Co-Operative, Inc., Value Drug Company, Kim Mahaffay and others
Defendant:
Impax Laboratories, Inc., Endo Health Solutions Inc., Endo Pharmaceuticals Inc. and others
Cause Of Action: 28 U.S.C. § 1331 Federal Question
United States v. Morton Grove Pharmaceuticals Inc et al
as 1:2022cv04367
Plaintiff:
United States
Defendant:
Morton Grove Pharmaceuticals Inc and Gopalakrishnan Venkatesan
Cause Of Action: 21 U.S.C. § 841 Forfeiture Property-Drugs
AltaThera Pharmaceuticals LLC v. Hyloris Pharmaceuticals SA et al
as 1:2022cv04620
Plaintiff:
AltaThera Pharmaceuticals LLC
Defendant:
Hyloris Pharmaceuticals SA, Academic Pharmaceuticals Inc. and C. Stromberg, M.D. John
Shulruff Dental, Inc. v. Parnell Pharmaceuticals, Inc. et al
as 1:2022cv00558
Plaintiff:
Shulruff Dental, Inc.
Defendant:
Parnell Pharmaceuticals, Inc. and John Does,1-10
Cause Of Action: 47 U.S.C. § 227
In Re: Humira (Adalimumab) Antitrust Litigation
as 1:2019cv01873
Defendant:
MYLAN PHARMACEUTICALS, INC., SANDOZ, INC., MOMENTA PHARMACEUTICALS, INC. and others
Plaintiff:
UFCW LOCAL 1500 WELFARE FUND, Plaintiffs, Locals 302 & 612 of the International Union of Operating Engineers-Employers Construction Industry Health and Security Trust Fund and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation
Law Enforcement Health Benefits Inc. v. Trudeau et al
as 3:2021cv50215
Defendant:
Questcor International, Ltd., Mallinckrodt ARD IP Unlimited CO., Mallinckrodt Pharma IP Trading Unlimited CO. and others
Plaintiff:
Law Enforcement Health Benefits Inc.
Cause Of Action: 28 U.S.C. § 1332
Monster Energy Company v. Vital Pharmaceuticals, Inc. et al
as 1:2021cv03067
Defendant:
John H Owoc, Jack Owoc and Vital Pharmaceuticals, Inc. a Florida Corporation doing business as VPX Sports
Plaintiff:
Monster Energy Company
SEC, et al v. Custable, et al
as 1:2003cv02182
Defendant:
Blagman Media International, Inc., Thermoelastic Technologies, Inc., Active Investments, Inc. and others
Intervenor Plaintiff:
United States of America
Plaintiff:
U.S. Securities and Exchange Commission
Intervenor:
Charter One Bank, N.A.
Petitioner:
Mr. Brad Hare
Receiver:
Mark D Toljanic
Cause Of Action: 15 U.S.C. § 78 m(a) Securities Exchange Act
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
